BackOptimizeRx Overview
OptimizeRx Corp

OptimizeRx Target Price

Where could OPRX trade next? Consensus target price: $11.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.87

Average Target Price

$10.8337.7% upside

6 analysts in the last 4 months

High: $14 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-14UBS$1139.8% upsideOpen
2026-08-13Stifel Nicolaus$1252.5% upsideOpen
2026-05-13UBS$1027.1% upsideOpen
2026-05-13Lake Street$1139.8% upsideOpen
2026-05-13Stephens$711.1% downsideOpen
2026-05-13Stifel Nicolaus$1477.9% upsideOpen
2026-03-06Stifel NicolausDavid Grossman$17116% upsideOpen
2025-10-10UBS$23192.2% upsideOpen
2024-04-04JMP SecuritiesConstantine Davides$1590.6% upsideOpen

OptimizeRx (OPRX) FAQ

OptimizeRx posts a target price of $11. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $11 for OPRX means covering analysts, on average, see the stock 37.7% upside of $7.87 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for OPRX's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; OptimizeRx's other metric pages and overview cover the third.

Judging OptimizeRx against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $11 here, then scan peer and history charts to see if the gap is persistent.